Literature DB >> 11900563

Xanthochromia.

Jonathan A Edlow1, Kathy S Bruner, Gary L Horowitz.   

Abstract

CONTEXT: Diagnosis of subarachnoid hemorrhage is usually established by computed tomographic scanning; however, in a few patients, lumbar puncture to examine the cerebrospinal fluid for erythrocytes and xanthochromia is necessary. Some authorities recommend delaying lumbar puncture by 12 hours following onset of symptoms to ensure sufficient time has elapsed for xanthochromia to develop. This recommendation is based on measuring xanthochromia by spectrophotometry. Our hypothesis was that very few hospital laboratories in the United States use this method.
OBJECTIVE: To determine the percentage of hospital clinical laboratories that measure for xanthochromia using spectrophotometry. DESIGN, SETTING, AND PARTICIPANTS: Mail survey to 3500 hospital clinical laboratory directors (in collaboration with the College of American Pathologists). Surveys were mailed in January 2001 and the results tabulated 1 month later. Participation was voluntary. MAIN OUTCOME MEASURES: Percentage of hospital clinical laboratories that use spectrophotometry versus visual inspection.
RESULTS: Of the 3500 laboratories surveyed, 2551 (72.9%) responded. Of these, 1944 (76.2%) indicated that they evaluated for xanthochromia. Of the 1952 laboratories that answered the question "How do you report your results?" 1947 (99.7%) reported using visual inspection.
CONCLUSIONS: When evaluating for xanthochromia in cerebrospinal fluid, nearly all hospital clinical laboratories in the United States use visual inspection. Given this current reality, the recommendation of delaying lumbar puncture by 12 hours needs to be reassessed.

Entities:  

Mesh:

Year:  2002        PMID: 11900563     DOI: 10.5858/2002-126-0413-X

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  15 in total

Review 1.  Diagnosis of subarachnoid hemorrhage.

Authors:  Jonathan A Edlow
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Spectrophotometry of cerebrospinal fluid in suspected subarachnoid haemorrhage.

Authors:  Anne Cruickshank; Robert Beetham; Ian Holbrook; Ian Watson; Philip Wenham; Geoffrey Keir; Peter White; William Egner
Journal:  BMJ       Date:  2005-01-15

3.  CSF spectrophotometry in questionable SAH: a continental divide.

Authors:  Linda M Sandhaus
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 4.  Spectrophotometry for cerebrospinal fluid pigment analysis.

Authors:  Axel Petzold; Lindsay T Sharpe; Geoffrey Keir
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

5.  Clearing of red blood cells in lumbar puncture does not rule out ruptured aneurysm in patients with suspected subarachnoid hemorrhage but negative head CT findings.

Authors:  D Cressler Heasley; Mona A Mohamed; David M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

6.  Proceedings of the 10th Asian Pacific Congress of Clinical Biochemistry in conjunction with the Australasian Association of Clinical Biochemists' 42nd Annual Scientific Conference.

Authors: 
Journal:  Clin Biochem Rev       Date:  2004

Review 7.  Intracranial hemorrhage.

Authors:  J Alfredo Caceres; Joshua N Goldstein
Journal:  Emerg Med Clin North Am       Date:  2012-08       Impact factor: 2.264

8.  Emergency Neurological Life Support: Subarachnoid Hemorrhage.

Authors:  Brian L Edlow; Owen Samuels
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

9.  Comparison of Cerebrospinal Fluid Biomarkers for Differential Diagnosis of Acute Bacterial and Viral Meningitis with Atypical Cerebrospinal Fluid Characteristics.

Authors:  Sérgio Monteiro de Almeida; Suélen Maria Parizotto Furlan; Arianne Maris Munhoz Cretella; Bruna Lapinski; Keite Nogueira; Laura Lucia Cogo; Luine Rosele Renaud Vidal; Meri Bordignon Nogueira
Journal:  Med Princ Pract       Date:  2019-09-03       Impact factor: 1.927

Review 10.  Emergency neurological life support: subarachnoid hemorrhage.

Authors:  Jonathan A Edlow; Owen Samuels; Wade S Smith; Scott D Weingart
Journal:  Neurocrit Care       Date:  2012-09       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.